SCHEMBL18667993

SCHEMBL18667993

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-n5c6cc7ccccc7cc6c6c7ccccc7c7ccccc7c65)cc4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSPO P30536 3/20 0.35
HDAC4 P56524 1/20 0.35
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
PTGER4 P35408 1/20 0.34
KDR P35968 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
NPY5R Q15761 2/20 0.31
PTPN1 P18031 1/20 0.31
NR3C1 P04150 1/20 0.31
KMT2A Q03164 1/20 0.30
IL1R1 P14778 1/20 0.30
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19131686 0.96 L3MBTL1 (0.37) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL23917170 0.96 KDM4E (0.39) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL19131235 0.95 L3MBTL1 (0.40) KDM4EATML3MBTL1TSPOJAK2
SCHEMBL19844150 0.93 KDM4E (0.35) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL19844142 0.91 KDM4E (0.46) KDM4EATML3MBTL1HDAC4JAK2
SCHEMBL20075327 0.91 JAK2 (0.34) KDM4EATML3MBTL1TSPOJAK2
SCHEMBL19132346 0.90 L3MBTL1 (0.53) KDM4EATML3MBTL1TSPOHDAC4
SCHEMBL24500383 0.89 KDM4E (0.34) KDM4EATML3MBTL1
SCHEMBL18668061 0.89 KDM4E (0.46) KDM4EATML3MBTL1HDAC4JAK2
SCHEMBL18668067 0.88 KDM4E (0.47) KDM4EATML3MBTL1HDAC4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
WO-2017047992-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2017-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 KDM4E 2554/4885ATM 3310/4885L3MBTL1 856/4885
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 KDM4E 2554/4885ATM 3310/4885L3MBTL1 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.